If you're seeing this message, that means JavaScript has been disabled on your browser.Please enable JavaScript to make this website work.

Sidansai (斯丹赛生物)

Shanghai, China

Biotechnology

51 – 200

Sidansai (斯丹赛生物) is engaged in the research and application of CAR-T (Chimeric Antigen Receptor T-Cell Immunotherapy) technology.

Unlock unlimited company data

As our subscriber, you can search and filter over 100,000 companies for your fundraising, investing, or sales needs.

Just $0.17 per day

Our subscriber community includes professionals from these companies:

501 – 1,000 employees

0 job positions

51 – 200 employees

0 job positions

51 – 200 employees

0 job positions

11 – 50 employees

0 job positions

5,001 – 10,000 employees

0 job positions

11 – 50 employees

0 job positions

Tired of ads? Enjoy an ad-free experience by signing up.